Literature DB >> 20682001

CD95 is not functional in human erythrocytes.

D Sagan1, N Jermnim, Orathai Tangvarasittichai.   

Abstract

INTRODUCTION: The CD95 pathway is a potent inducer of apoptosis in nucleated cells and this death receptor is important for proper blood cell development. Although it is expressed in red blood cells, its functional role in erythrocytes is not well documented. These anucleated cells can undergo cell death via eryptosis, a process showing similarities to apoptosis of nucleated cells. This mode of cell death is mainly triggered by oxidative stress or energy depletion.
METHODS: CH11 was added to the purified human erythrocytes for induction of phosphatidylserine (PS) exposure. AnnexinV-FITC was used as a probe for PS detection.
RESULTS: No significantly enhanced PS-positive cell fraction could be observed after erythrocytes were treated with CH11.
CONCLUSION: Based on some key features for an activated CD95 system, this death receptor has been considered to induce PS exposure. However, we give evidence, that CD95 is not functional in red blood cells and that activation of this death receptor does not lead to the exposure of phosphatidylserine.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20682001     DOI: 10.1111/j.1751-553X.2010.01245.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  3 in total

1.  Physiology and pathophysiology of eryptosis.

Authors:  Florian Lang; Elisabeth Lang; Michael Föller
Journal:  Transfus Med Hemother       Date:  2012-09-06       Impact factor: 3.747

2.  Human-specific bacterial pore-forming toxins induce programmed necrosis in erythrocytes.

Authors:  Timothy J LaRocca; Elizabeth A Stivison; Eldad A Hod; Steven L Spitalnik; Peter J Cowan; Tara M Randis; Adam J Ratner
Journal:  MBio       Date:  2014-08-26       Impact factor: 7.867

Review 3.  Role of Extrinsic Apoptotic Signaling Pathway during Definitive Erythropoiesis in Normal Patients and in Patients with β-Thalassemia.

Authors:  Olga Raducka-Jaszul; Dżamila M Bogusławska; Natalia Jędruchniewicz; Aleksander F Sikorski
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.